APHINITY Combo Details Contain No Surprise, Puma's Nerlynx May Benefit

Details of Roche's early stage breast cancer study APHINITYs were positive as previously headlined, but it's likely to confine use of Perjeta, Herceptin and chemotherapy to higher-risk, node-positive patients.